Product Details

Acamprosate Calcium DR Tablets

Pronunciation: ah-kam-PRO-sate

Strength:
333mg
NDC-9:
68382-0569
Dosage Form:
DR Tablet
TE Code:
AB
Reference Listed Drug:
Campral®
Shape:
Round
Color:
White to Off-White
Imprint Code:
569
Therapeutic Category:
Central Nervous System Agent
Product Status:
Active
Acamprosate Calcium DR Tablets

* NOT TO SCALE

Indications

Acamprosate calcium delayed-release tablets are indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. Treatment with acamprosate calcium delayed-release tablets should be part of a comprehensive management program that includes psychosocial support.

The efficacy of acamprosate calcium delayed-release tablets in promoting abstinence has not been demonstrated in subjects who have not undergone detoxification and not achieved alcohol abstinence prior to beginning acamprosate calcium delayed-release tablets treatment. The efficacy of acamprosate calcium delayed-release tablets in promoting abstinence from alcohol in polysubstance abusers has not been adequately assessed.

Special Instructions

Keep this product, and all medications, out of the reach of children. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight container (USP).

Allergen Information

Click here to request allergen information.

Case Information

Bottle of 100  
NDC:68382-0569-28  
UPC:368382569288  
Case Qty:24  
Case Dimensions (LxWxH - inches):13.26 x 8.85 x 5.11  
Case Weight:8.7  
Bottle Dimensions (WxH - inches):2.21 x 3.97  
Bottle Size:150cc  
Product Shelf Life (months):24